Skip to main content Accessibility help
×
Home

Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method

  • A.D. Sadovnick (a1), N.J. Risch (a2), G.C. Ebers (a3) and the Canadian Collaborative Study Group

Abstract:

Background:

Results from the Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis (MS)-Phase 1 (CCPGSMS-Phase 1) together with other family data published since 1982 have led to the following conclusions about the etiology of MS: (i) genetic and non-genetic (environmental) factors are involved in the etiology of MS on a population basis; (ii) the familial aggregation of MS is genetic; (iii) maternal factors do not influence the risk for siblings to develop MS; and (iv) MS appears to be oligogenic. The present paper describes the rationale and methodology for the CCPGSMS-Phase 2.

Methods:

The CCPGSMS-Phase 2 is a nation-wide collaborative effort involving all the 15 Canadian MS clinics. A series of structured questionnaires is administered to MS index cases, spouse controls and mothers of index cases and spouse controls (if available) by trained interviewers. Blood samples are taken for molecular genetic studies. This national effort is coordinated by the MS Clinics in Vancouver and London.

Results:

The CCPGSMS-Phase 2 is in progress so specific results are not available. The study is designed to (i) increase the database for genetic epidemiological/molecular genetic research and (ii) gather population-based data to further our understanding of the non-genetic factors in the etiology of MS.

Conclusions:

It is anticipated that the results from this study will impact on the eventual prevention, cure and treatment of MS.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method
      Available formats
      ×

Copyright

Corresponding author

GF401 Koerner Pavilion, VHHSSC-UBC, 2211 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 2B5

References

Hide All
1.Ebers, GC, Sadovnick, AD, Risch, NJ and the Canadian Collaborative Study Group. Familial aggregation in multiple sclerosis is genetic. Nature 1995; 377: 150151.
2.Sadovnick, AD, Ebers, GC, Dyment, D, et al. Evidence for the genetic basis of multiple sclerosis. Lancet 1996; 347: 17281730.
3.Ebers, GC, Kukay, K, Bulman, DE, et al. A full genome search in multiple sclerosis. Nature Genet 1996; 13: 472476.
4.Ebers, GC, Bulman, DE, Sadovnick, AD, et al. A population-based twin study in multiple sclerosis. N Engl J Med 1986; 315: 16381642.
5.Sadovnick, AD, Armstrong, H, Rice, GPA, et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993; 33: 281285.
6.Mumford, CJ, Wood, NW, Kellar-Wood, H, et al. The British Isles survey of multiple sclerosis in twins. Neurology 1994; 44: 1115.
7.Sadovnick, AD, Baird, PA, Ward, RH. Multiple sclerosis: Updated risks for relatives. Am J Med Genet 1988; 29: 533541.
8.Carton, H, Vlietinck, R, Debruyne, J, et al. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 1997; 62: 329333.
9.Robertson, NM, Fraser, M, Deans, J, et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996; 119: 449455.
10.Sawcer, S, Jones, HB, Feakes, R, et al. A genome screen in multiple sclerosis reveals susceptibility on chromosome 6p21 and 17q22. Nature Genet 1996; 13: 464468.
11.The Multiple Sclerosis Genetics Group. Complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet 1996; 13: 469471.
12.Robertson, NP, O’Riordan, J, Clayton, D, et al. Conjugal multiple sclerosis. J Neurol 1995; 242: S8.
13.Sibley, WA, Bamford, CR, Clark, K. Triggering factors in multiple sclerosis. In: Poser, CM, Paty, DW, Scheinberg, L, et al., eds. The Diagnosis of Multiple Sclerosis. New York: Thieme-Stratton Inc., 1984; chap 2, 15.
14.Ebers, GC, Sadovnick, AD. Epidemiology. In: Paty, DE, Ebers, GC, eds. Multiple Sclerosis. Philadephia: FA Davis Company, 1997; chap 2, 1617.
15.Poser, CM, Paty, DW, Scheinberg, L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227231.
16.Kurtzke, JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 14441452.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed